- Home
- ACLX vs CHX Comparison
ACLX vs CHX Comparison
Compare ACLX & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- CHX
- Stock Information
- Founded
- ACLX 2015
- CHX 1882
- Country
- ACLX United States
- CHX United States
- Employees
- ACLX N/A
- CHX N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- CHX Industrial Machinery/Components
- Sector
- ACLX Health Care
- CHX Industrials
- Exchange
- ACLX Nasdaq
- CHX Nasdaq
- Market Cap
- ACLX 3.5B
- CHX 4.7B
- IPO Year
- ACLX 2022
- CHX N/A
- Fundamental
- Price
- ACLX $67.16
- CHX $26.14
- Analyst Decision
- ACLX Strong Buy
- CHX Strong Buy
- Analyst Count
- ACLX 14
- CHX 3
- Target Price
- ACLX $111.42
- CHX $37.67
- AVG Volume (30 Days)
- ACLX 567.9K
- CHX 3.0M
- Earning Date
- ACLX 08-07-2025
- CHX 07-23-2025
- Dividend Yield
- ACLX N/A
- CHX 1.45%
- EPS Growth
- ACLX N/A
- CHX N/A
- EPS
- ACLX N/A
- CHX 1.51
- Revenue
- ACLX $76,809,000.00
- CHX $3,576,306,000.00
- Revenue This Year
- ACLX N/A
- CHX N/A
- Revenue Next Year
- ACLX $112.68
- CHX $3.56
- P/E Ratio
- ACLX N/A
- CHX $17.31
- Revenue Growth
- ACLX N/A
- CHX N/A
- 52 Week Low
- ACLX $47.86
- CHX $21.92
- 52 Week High
- ACLX $107.37
- CHX $35.94
- Technical
- Relative Strength Index (RSI)
- ACLX 59.84
- CHX 57.89
- Support Level
- ACLX $63.13
- CHX $24.60
- Resistance Level
- ACLX $67.83
- CHX $26.45
- Average True Range (ATR)
- ACLX 2.52
- CHX 0.68
- MACD
- ACLX 0.14
- CHX 0.07
- Stochastic Oscillator
- ACLX 90.30
- CHX 75.11
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.